Unresectable Malignant Solid Neoplasm Active Not Recruiting Phase 1 Trials for Adavosertib (DB11740)

IndicationStatusPhase
DBCOND0110416 (Unresectable Malignant Solid Neoplasm)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04197713
Testing the Sequential Combination of the Anti-cancer Drugs Olaparib Followed by Adavosertib (AZD1775) in Patients With Advanced Solid Tumors With Selected Mutations and PARP Resistance, STAR StudyTreatment